(CLVT) CLARIVATE - Ratings and Ratios

Clarivate Plc is a global information services provider, operating across multiple regions including the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company's business is structured into three primary segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. This segmentation allows Clarivate to cater to a wide range of clients, including academic institutions, government agencies, pharmaceutical companies, law firms, and other professional services organizations. By offering a diverse portfolio of products and services, Clarivate supports its clients in managing research information, protecting intellectual property, and informing strategic decisions.

Within its Academia & Government segment, Clarivate provides tools such as Web of Science and InCites, which enable the analysis and exploration of the academic research landscape. Additionally, the company offers ProQuest One and Ebook Central, comprehensive content collections designed to provide institutions with cost-effective access to a broad range of academic resources. Furthermore, products like Alma and Polaris facilitate the management of academic resources and services, connecting users and supporting research publications. These solutions are crucial for academic institutions aiming to optimize their research output and manage their resources efficiently.

In the Intellectual Property segment, Clarivate offers a suite of services and tools designed to support the protection and management of intellectual property assets. This includes Patent and Trademark Renewals, which streamlines paralegal and administrative tasks associated with patent and trademark protection and maintenance. The company also provides CompuMark and Derwent, solutions that support critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle. Moreover, IPFolio and Foundation IP create a structured environment for the protection and management of global patent and trademark assets, ensuring that companies can safeguard their intellectual property effectively.

Clarivate's Life Sciences & Healthcare segment is equipped with solutions such as Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, which support the development of new drugs and medical devices from discovery to clinical trials. The company also offers Cortellis Regulatory Intelligence and OFF-X, tools that monitor drug safety issues and help adhere to regulatory protocols, ensuring compliance and minimizing risks. Additionally, Real World Data and Optimize provide insights that inform commercial launch strategies and set pricing for optimal reimbursement, supporting pharmaceutical companies in navigating complex healthcare markets.

With a history dating back to 1864, Clarivate Plc has evolved significantly, formerly operating as Clarivate Analytics Plc before changing its name in May 2020. Headquartered in London, the United Kingdom, the company serves a diverse client base, including corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. Its global presence and comprehensive suite of services position Clarivate as a leading provider of information services, supporting clients in making informed decisions and driving innovation. For more information, visit https://www.clarivate.com. The company's stock is listed on the NYSE under the ticker CLVT, with the ISIN JE00BJJN4441, classified as a common stock within the Research & Consulting Services sub-industry.